Your session is about to expire
← Back to Search
Videolaryngoscope vs Regular Laryngoscope for Infant Intubation (NasoVISI Trial)
NasoVISI Trial Summary
This trial is studying whether using a videolaryngoscope is better than using a regular laryngoscope for intubating infants for cardiothoracic surgery or cardiac catheterization.
NasoVISI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNasoVISI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NasoVISI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had a hard time breathing with a tube in your throat in the past.I am a newborn, less than 1 year old.You are not at least 36 weeks pregnant.My weight is under 2 kg.I have had issues with my airways in the past.Your physical examination shows that it might be hard to put a breathing tube in.I have a tube in my windpipe for breathing.I will be given a muscle relaxant before being put on a breathing tube.I am scheduled for heart or chest surgery under general anesthesia that will last more than 30 minutes.
- Group 1: Videolaryngoscopy
- Group 2: Direct Laryngoscopy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current participant count in this clinical experiment?
"Affirmative. It is evident from the information available on clinicaltrials.gov that this research project began to recruit participants on June 6th 2022 and was recently refreshed on December 5th 2022. The study necessitates 1400 patients across 8 medical sites."
Am I an eligible participant in this medical experiment?
"To participate in this medical trial, patients must have anoxia and be younger than a year old. The study is hoping to enroll up to 1400 individuals."
Is this research project enrolling participants at the present time?
"Indeed, the information on clinicaltrials.gov demonstrates that this study is actively engaging with potential participants. It was initially posted on June 6th 2022 and recently updated in December 5th of the same year. The research requires 1400 patients from 8 distinct sites to partake in this trial."
How many venues are administering this research study?
"There are 8 locations that are presently enrolling participants, including Seattle Children's Hospital in Washington, Dell Children's Medical Center in Texas and Emory University in Georgia. Additionally, there 5 other sites offering this trial."
Are individuals above the age of 30 eligible to take part in this investigation?
"This clinical trial is seeking participants who are between 1 and 365 days of age."
Share this study with friends
Copy Link
Messenger